Evidence map›Paper›PMID 41377377›Full record

ArticleAnnals of medicine and surgery (2012)2025

Clinicopathological and molecular mechanisms of cribriform morular thyroid carcinoma: a case report and a literature review.

Xi Zhang, Yuanshi Lv, Wendi Yan, Hongzhi Lu, Hui Jin, Hong Gao

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xi ZhangDepartment of Thyroid-Head & Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, People's Republic of China.
Yuanshi LvDepartment of Thyroid-Head & Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, People's Republic of China.
Wendi YanDepartment of Pathology, Jilin Cancer Hospital, Changchun, People's Republic of China.
Hongzhi LuDepartment of Thyroid-Head & Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, People's Republic of China.
Hui JinDepartment of Thyroid-Head & Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, People's Republic of China.
Hong GaoDepartment of Thyroid-Head & Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and importance: Cribriform morular thyroid carcinoma (CMTC) is a rare malignant thyroid carcinoma, mainly seen in young Asian women. CMTC is related to the activation of the WNT/β-catenin signaling pathway, so CMTC is usually closely related to familial adenomatous polyposis (FAP). Case presentation: The patient was a 13-year-and-11-month-old girl with a right neck mass. After total thyroidectomy and bilateral lymph node dissection, the tumor's pathological report is CMTC, and 31 lymph nodes exhibited metastatic carcinoma. Adenomatous polyposis coli (APC) gene mutation has been detected. Clinical discussion: CMTC has typical cribriform and morular structures under microscope. It is associated with the WNT/β-catenin signaling pathway through inactivating mutations in the APC, CTNNB1, and AXIN1 genes, thereby enabling WNT gene expression and participating in proliferation, invasion, dedifferentiation, and tumorigenesis. Conclusion: CMTC is usually closely related to FAP. It requires clinical attention, and the patient's intestinal condition still needs to be closely monitored after surgery.

Indexed as

APC mutationscribriform morular thyroid carcinomafamilial adenomatous polyposisthyroid carcinomaWNT/β-catenin signaling pathway

Identifiers

PMID41377377
PMCPMC12688954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.